Accessibility Help | Sitemap | Contact Us | Customer Support Freephone 1 800 33 33 77
Ireland Change Country
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education & Training  |  For Patients  |  Customer Support
You are here: Home > News & Media > Corporate News
Print

Corporate News


These press releases are intended as reference information for investors and journalists. The information contained in each press release was current at the time of issuance, and KCI assumes no responsibility for updating the information to reflect subsequent developments.

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Displaying 1 to 7 of 7 News Items For 2015
29th July 2015
Acelity L.P. Inc. Reports Second Quarter and First Half Financial Results for 2015

U.S. Advanced Wound Therapeutics revenue grew 10%

14th May 2015
Nanova™ Therapy System Now Available from Acelity

Device Combines Absorbent Dressing with Negative Pressure Facilitates Earlier Patient Discharge

17th February 2015
Acelity L.P. Inc. Reports Fourth Quarter and Full Year Financial Results for 2014

  • Fourth quarter revenue grew 6.5% compared to the prior-year period, on a constant currency basis
  • Fourth quarter 2014 Adjusted EBITDAfrom continuing operations1 grew 5.4% compared to the prior-year period, on a constant currency basis
  • Fourth quarter loss from continuing operations was $30.9 million compared to $52.0 million for the prioryear period
Displaying 1 to 7 of 7 News Items For 2015

  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Legal Notice | Privacy Policy | Contact Us


Copyright © 1998 – 2013 KCI Licensing, Inc All Rights Reserved.   DSL# 09-03-193.IE

The information included in this Web site has been prepared for and is intended for viewing exclusively within the Republic of Ireland. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications and restriction in different countries.